BACKGROUND: Lung transplantation is nowadays the standard therapy for certain well-defined chronic end-stage lung diseases, even in patients on mechanical ventilation or extracorporeal life support. While these latter techniques have been used worldwide as bridging options to lung transplantation for listed patients, they are not commonly used in previously healthy patients developing acute not-reversible lung failure. METHODS: We will discuss two patients without any relevant medical history developing acute lung failure evolving to irreversible acute fibrinous and organising pneumonia (AFOP), thus listed for urgent lung transplantation. RESULTS: The patients recovered well, and both are still alive. CONCLUSIONS: In the absence of clear guidelines, our approach showed, in these patients, the possible benefits of lung transplantation regarding survival in AFOP.
BACKGROUND: Lung transplantation is nowadays the standard therapy for certain well-defined chronic end-stage lung diseases, even in patients on mechanical ventilation or extracorporeal life support. While these latter techniques have been used worldwide as bridging options to lung transplantation for listed patients, they are not commonly used in previously healthy patients developing acute not-reversible lung failure. METHODS: We will discuss two patients without any relevant medical history developing acute lung failure evolving to irreversible acute fibrinous and organising pneumonia (AFOP), thus listed for urgent lung transplantation. RESULTS: The patients recovered well, and both are still alive. CONCLUSIONS: In the absence of clear guidelines, our approach showed, in these patients, the possible benefits of lung transplantation regarding survival in AFOP.
Entities:
Keywords:
Acute fibrinous and organising pneumonia; Extracorporeal life support; Extracorporeal membrane oxygenation; Interstitial lung disease; Urgent lung transplantation
Authors: Konrad Hoetzenecker; Stefan Schwarz; Moritz Muckenhuber; Alberto Benazzo; Florian Frommlet; Thomas Schweiger; Orsolya Bata; Peter Jaksch; Negar Ahmadi; Gabriella Muraközy; Helmut Prosch; Helmut Hager; Georg Roth; György Lang; Shahrokh Taghavi; Walter Klepetko Journal: J Thorac Cardiovasc Surg Date: 2017-12-07 Impact factor: 5.209
Authors: B Renaud-Picard; T Dégot; D Biondini; N Weingertner; J Reeb; M P Chenard; R Kessler Journal: Transplant Proc Date: 2015-01-15 Impact factor: 1.066
Authors: A Akabayashi; E Nakazawa; R Ozeki-Hayashi; K Tomiyama; K Mori; R A Demme; A Akabayashi Journal: Transplant Proc Date: 2018-03-10 Impact factor: 1.066
Authors: Mary Beth Beasley; Teri J Franks; Jeffrey R Galvin; Bernadette Gochuico; William D Travis Journal: Arch Pathol Lab Med Date: 2002-09 Impact factor: 5.534
Authors: Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Lam-Phuong Nguyen; Stella Ahdoot; Narin Sriratanaviriyakul; Yanhong Zhang; Nicholas Stollenwerk; Michael Schivo; Richart Harper Journal: J Investig Med High Impact Case Rep Date: 2016-04-13